Literature DB >> 7223658

Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects.

R E Goldstein, L C Corash, J F Tallman, C R Lake, J Hyde, C C Smith, N L Capurro, J C Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7223658     DOI： 10.1016/0002-9149(81)90222-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  8 in total

Review 1.  The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.

Authors:  B N Prichard; R J Walden
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 2.  Central nervous system mechanisms in blood pressure control.

Authors:  A D Struthers; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 3.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

4.  Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study.

Authors:  N A Silverman; R Wright; S Levitsky
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

Review 5.  Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation.

Authors:  P B Molinoff
Journal:  Drugs       Date:  1984       Impact factor: 9.546

6.  Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers.

Authors:  R J Walden; B Tomlinson; B Graham; J B Liu; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

7.  Effects of chronic metoprolol and sulphinpyrazone on human lymphocyte beta-adrenoceptors.

Authors:  A De Blasi; M Cortellaro; C Costantini
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

8.  Blood pressure and catecholamines following exercise during selective beta-blockade in hypertension.

Authors:  R Vandongen; B Margetts; L J Beilin; N deKlerk; P Rogers
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.